BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28824637)

  • 21. Pichia pastoris-produced mucin-type fusion proteins with multivalent O-glycan substitution as targeting molecules for mannose-specific receptors of the immune system.
    Gustafsson A; Sjöblom M; Strindelius L; Johansson T; Fleckenstein T; Chatzissavidou N; Lindberg L; Angström J; Rova U; Holgersson J
    Glycobiology; 2011 Aug; 21(8):1071-86. PubMed ID: 21474492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of DC-SIGN to glycoproteins expressed in glycoengineered Pichia pastoris.
    Cukan MC; Hopkins D; Burnina I; Button M; Giaccone E; Houston-Cummings NR; Jiang Y; Li F; Mallem M; Mitchell T; Moore R; Nylen A; Prinz B; Rios S; Sharkey N; Zha D; Hamilton S; Li H; Stadheim TA
    J Immunol Methods; 2012 Dec; 386(1-2):34-42. PubMed ID: 22982058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into the pathogenesis of chronic lymphocytic leukemia.
    Klein U; Dalla-Favera R
    Semin Cancer Biol; 2010 Dec; 20(6):377-83. PubMed ID: 21029776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered N-glycosylation in CD45 and regulatory roles of altered N-glycosylation in galectin-1-induced growth inhibition in human diffuse large B cell lymphoma.
    Suzuki O; Nozawa Y; Abe M
    Oncol Rep; 2005 Jan; 13(1):109-14. PubMed ID: 15583810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation.
    Smit LA; van Maldegem F; Langerak AW; van der Schoot CE; de Wit MJ; Bea S; Campo E; Bende RJ; van Noesel CJ
    Haematologica; 2006 Jul; 91(7):903-11. PubMed ID: 16818277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B cell receptor and antigens in CLL.
    Agathangelidis A; Ntoufa S; Stamatopoulos K
    Adv Exp Med Biol; 2013; 792():1-24. PubMed ID: 24014290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells.
    Efremov DG; Gobessi S; Longo PG
    Autoimmun Rev; 2007 Dec; 7(2):102-8. PubMed ID: 18035318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.
    Del Giudice I; Chiaretti S; Santangelo S; Tavolaro S; Peragine N; Marinelli M; Ilari C; Raponi S; Messina M; Nanni M; Mauro FR; Piciocchi A; Bontempi K; Rossi D; Gaidano G; Guarini A; Foà R
    Am J Hematol; 2014 Jan; 89(1):74-82. PubMed ID: 24030933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells.
    Seda V; Mraz M
    Eur J Haematol; 2015 Mar; 94(3):193-205. PubMed ID: 25080849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity of DC-SIGN for mannose- and fucose-containing glycans.
    van Liempt E; Bank CM; Mehta P; Garciá-Vallejo JJ; Kawar ZS; Geyer R; Alvarez RA; Cummings RD; Kooyk Yv; van Die I
    FEBS Lett; 2006 Nov; 580(26):6123-31. PubMed ID: 17055489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin.
    Holla A; Skerra A
    Protein Eng Des Sel; 2011 Sep; 24(9):659-69. PubMed ID: 21540232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic hypermutation and B-cell lymphoma.
    Dunn-Walters D; Thiede C; Alpen B; Spencer J
    Philos Trans R Soc Lond B Biol Sci; 2001 Jan; 356(1405):73-82. PubMed ID: 11205334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotyped B cell receptors in B cell leukemias and lymphomas.
    Darzentas N; Stamatopoulos K
    Methods Mol Biol; 2013; 971():135-48. PubMed ID: 23296962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients.
    Saeland E; Belo AI; Mongera S; van Die I; Meijer GA; van Kooyk Y
    Int J Cancer; 2012 Jul; 131(1):117-28. PubMed ID: 21823122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterisation of insulin-like growth factor receptors and insulin receptors in the human placenta using lectin affinity methods.
    Masnikosa R; Baricević I; Jones DR; Nedić O
    Growth Horm IGF Res; 2006 Jun; 16(3):174-84. PubMed ID: 16730207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signaling pathways activated by the B-cell receptor in chronic lymphocytic leukemia.
    Scupoli MT; Pizzolo G
    Expert Rev Hematol; 2012 Jun; 5(3):341-8. PubMed ID: 22780213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of sialylated O-linked glycans in Pichia pastoris.
    Hamilton SR; Cook WJ; Gomathinayagam S; Burnina I; Bukowski J; Hopkins D; Schwartz S; Du M; Sharkey NJ; Bobrowicz P; Wildt S; Li H; Stadheim TA; Nett JH
    Glycobiology; 2013 Oct; 23(10):1192-203. PubMed ID: 23893788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GALNT11 as a new molecular marker in chronic lymphocytic leukemia.
    Libisch MG; Casás M; Chiribao M; Moreno P; Cayota A; Osinaga E; Oppezzo P; Robello C
    Gene; 2014 Jan; 533(1):270-9. PubMed ID: 24076351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related (DC-SIGNR): friend or foe?
    Soilleux EJ
    Clin Sci (Lond); 2003 Apr; 104(4):437-46. PubMed ID: 12653690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.